• 1
    Johnson PJ & McFarlane IG. Meeting report. Int Autoimmune Hepatitis Group Hepatology 1993; 18:9981005.
  • 2
    Czaja AJ. Autoimmune hepatitis: evolving concepts and treatment stategies. Dig Dis Sci 1995; 40:43556.
  • 3
    Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996; 334:897903.
  • 4
    Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde KH. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987; 1:2924.
  • 5
    Manns M. Autoantibodies and antigens in liver disease − updated. J Hepatol 1989; 9:27280.
  • 6
    Morshed SA, Parveen S, Nishioka M. Antibodies to cytoskeleton antigens in autoimmune liver diseases. In: KrawittEL, WiesnerRH, NishiokaM, eds. Autoimmune liver diseases, 2nd edn. Netherlands: Elsevier Science B. V., 1998:21756.
  • 7
    Matsuoka H, Chen M, Ando T et al. Frequency of antibody to soluble liver antigen in patients chronic liver diseases and their characteristics. Kanzo 1997; 3:1528.
  • 8
    Bartek J, Bartkova J, Taylor-Papadimitriou J et al. Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J 1986; 18:56575.
  • 9
    Kasper M, Stosiek P, Typlt H, Karsten U. Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues. Eur J Cancer Clin Oncol 1987; 23:13747.
  • 10
    Osborn M, Van Lessen G, Weber K, Kloppel G, Altmannsberger M. Methods in laboratory investigation. Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest 1986; 55:497504.
  • 11
    Ramaekers F, Huysmans A, Schaart G, Moesker O, Vooijs P. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987; 170:23549.
  • 12
    Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of cholestatic liver diseases: evidence that hepatocytes can express ‘bile duct-type’ cytokeratins. Histopathology 1989; 15:12535.
  • 13
    Kawahara H, Cadrin M, Perry G et al. Role of cytokeratin intermediate filaments in transhepatic transport and canalicular secretion. Hepatology 1990; 11:43548.
  • 14
    Katsuma Y, Swierenga SH, Marceau N, French SW. Selective rearrangement of cytokeratin filaments in cultured liver epithelial cells induced by nickel. J Hepatol 1987; 5:34454.
  • 15
    Swierenga SHH & MaLean JR. Further insights into mechanism of nickel-induced DNA damage: studies with cultured rat liver cells. In: BrownSS, Sunderman JrFW, eds. Progress in nickel toxicity. Oxford: Blackwell Scientific Publications, 1985:1014.
  • 16
    Oda M, Price VM, Fisher MM, Phillips PJ. Ultrastructure of bile canaliculi with special references to the surface coat and the pericanalicular web. Lab Invest 1974; 31:31423.
  • 17
    Jahn W. Visualization of a filamentous network in cryo sections of liver tissue. Eur J Cell Biol 1980; 20:3014.
  • 18
    French SW, Kondo I, Irie T, Ihrig TJ, Benson N, Munn R. Morphologic study of intermediate filaments in rat hepatocytes. Hepatology 1982; 2:2938.
  • 19
    Okanoue T, Ohta M, Fushiki S et al. Scanning electron microscopy of the liver cell cytoskeleton. Hepatology 1985; 5:16.
  • 20
    Katsuma Y, Marceau N, Ohta M, French SW. Cytokeratin intermediate filaments of rat hepatocytes: different cytoskeletal domains and their three-dimensional structure. Hepatology 1988; 8:55968.
  • 21
    Tolle HG, Weber K, Osborn M. Microinjection of monoclonal antibodies specific for one intermediate filament protein in cells containing multiple keratins allows insight into the composition of particular 10 nm filaments. Eur J Cell Biol 1985; 38:23444.
  • 22
    Tolle HG, Weber K, Osborn M. Microinjection of monoclonal antibodies to vimentin, desmin, and GFA in cells which contain more than one IF type. Exp Cell Res 1986; 162:46274.
  • 23
    Gawlitta W, Osborn M, Weber K. Coiling of intermediate filaments induced by microinjection of a vimentin-specific antibody does not interfere with locomotion and mitosis. Eur J Cell Biol 1981; 26:8390.
  • 24
    Klymkowsky MW. Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody. Nature 1981; 291:24951.
  • 25
    Klymkowsky MW, Miller RH, Lane EB. Morphology, behaviour and interaction of cultured epithelial cell after the antibody-induced disruption of keratin filament organization. J Cell Biol 1983; 96:494509.
  • 26
    Ku NO, Michie S, Oshima RG, Omary MB. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol 1995; 131:130314.
  • 27
    Ku NO, Michie SA, Soetikno RM et al. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J Clin Invest 1996; 98:103446.
  • 28
    Wachter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum Buschenfelde KH, Manns M. Characterization of liver cytokeratins as a major target antigen of anti-SLA antibodies. J Hepatol 1990; 11:2329.
  • 29
    Kurki P, Virtanen I, Lehto VP, Alfthan O, Salaspuro M. Antibodies to cytokeratin filaments in patients with alcoholic liver disease. Alcohol Clin Exp Res 1984; 8:2125.
  • 30
    Oda M, Azuma T, Komatsu H, Kaneko K, Nishizaki Y, Tsuchiya M. Formation of anti-cytokeratin antibody in primary biliary cirrhosis – its origin and pathologic significance. Hepatology 1988; 8:1416A.
  • 31
    Prasad S, Soldatenkov VA, Srinivasarao G, Dritschilo A. Identification of keratins 18, 19 and heat-shock protein 90β as candidate substrates of proteolysis during ionizing radiation-induced apoptosis of estrogen-receptor negative breast tumor cells. Int J Oncol 1998; 13:75764.
  • 32
    Caulin C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997; 138:137994.
  • 33
    Bombardieri E, Seregni E, Bogni A et al. Evaluation of CK19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trial. Int J Biol Markers 1994; 9:8995.
  • 34
    Omary MB & Ku NO. Intermediate filament proteins of the liver: emerging disease association and functions. Hepatology 1997; 25:10438.
  • 35
    Kim JW, Wierda WG, Kim YB. Immobilized IgG immune complex induces secretion of tumor necrosis factor-α by porcine alveolar macrophages. Am J Respir Cell Mol Biol 1991; 5:24955.
  • 36
    Davies KA, Peters AM, Beynon HL, Walport MJ. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest 1992; 90:207583.